Period 1 is the baseline. Before period 2, improved algorithms reduced the average number of data reviews per patient. Before period 3, additional data displays were included in Timely Interventions for Diabetes Excellence (TIDE) to reduce the time required for data review.
Source: Adapted from Ferstad JO, Vallon JJ, Jun D, et al. Population-level management of type 1 diabetes via continuous glucose monitoring and algorithm-enabled patient prioritization: precision health meets population health. Pediatr Diabetes 2021;22:982–91 with the permission of the authors
NEJM Catalyst (catalyst.nejm.org) © Massachusetts Medical Society